The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?

BACKGROUND: High concentrations of recombinant activated factor VII (rFVIIa) can stop bleeding in hemophilic patients. However the rFVIIa dose needed for stopping haemhorrage in off-label indications is unknown. Since thrombin is the main hemostatic agent, this study investigated the effect of rFVII...

Descripción completa

Detalles Bibliográficos
Autores principales: Altman, Raul, Scazziota, Alejandra, de Lourdes Herrera, Maria, Gonzalez, Claudio D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Latest therapeutic developments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885319/
https://www.ncbi.nlm.nih.gov/pubmed/20444280
http://dx.doi.org/10.1186/1477-9560-8-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885319/
https://www.ncbi.nlm.nih.gov/pubmed/20444280
http://dx.doi.org/10.1186/1477-9560-8-8

Ejemplares similares